NTLA Sets Date for 2025 Earnings Call—What Should Investors Watch Ahead of the Business Update?
Market Chameleon (Thu, 19-Feb 8:54 AM)
Market Chameleon (Fri, 6-Feb 7:33 AM)
FDA Clears Path for Intellia’s MAGNITUDE-2 Trial—Enrollment Resumes for Promising One-Time Therapy
Market Chameleon (Tue, 27-Jan 8:21 AM)
NTLA Sets the Stage for 2026 with High-Profile J.P. Morgan Healthcare Conference Presentation
Market Chameleon (Wed, 7-Jan 8:41 AM)
Market Chameleon (Mon, 5-Jan 8:44 AM)
Intellia Awards Inducement Grants: 12,600 RSUs Allocated to New Hires Under 2024 Plan
Market Chameleon (Mon, 8-Dec 8:25 AM)
